Please login to the form below

Not currently logged in
Email:
Password:

Aerospan

This page shows the latest Aerospan news and features for those working in and with pharma, biotech and healthcare.

Mylan raises offer for Meda to $9bn

Mylan raises offer for Meda to $9bn

Also due to launch shortly is Aerospan (flunisolide), an inhaler therapy for asthma - incorporating a spacer to improve drug delivery to the lungs - that Meda has said could achieve sales of

Latest news

  • Meda buys US respiratory firm Acton in $200m deal Meda buys US respiratory firm Acton in $200m deal

    Meda buys US respiratory firm Acton in $200m deal. Swedish pharma firm gains access to asthma treatment Aerospan. ... Meda is paying $125m upfront for Acton, which has been sitting on a US approval for an inhaled corticosteroid product called Aerospan

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics